NEW YORK — Food and animal safety firm Neogen said on Thursday that it has acquired Genetic Veterinary Sciences, a companion animal genetic testing firm that is doing business as Paw Print Genetics.
Financial and other terms of the deal were not disclosed.
Spokane, Washington-based Genetic Veterinary Sciences offers a range of genetic tests for dogs, cats, and birds under the brands Paw Print Genetics, Canine HealthCheck, My CatScan, and AvianDx.
"With the growth in pet parenting globally over the past five years, and particularly as a result of the COVID-19 pandemic, this acquisition will further expand the opportunities for our global genomics business," Marylinn Munson, VP of genomics at Neogen, said in a statement. "It is important for Neogen to continue expanding our portfolio of genomic tests and diversify our offerings in agriculture and food production to include enhanced testing for companion animals."
Lansing, Michigan-based Neogen, whose offerings include its GeneSeek line of livestock genomic testing solutions, has made a number of acquisitions in recent years including animal genomics business Scidera Genomics in 2013, Brazilian animal genomics lab Deoxi Biotecnologia in 2016, and Canadian animal genomics laboratory Delta Genomics Centre in 2019. In early 2020, it partnered with Gencove on the development of new animal genomics tests.